Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Cow (Bovine) Polyclonal GRM7 Primary Antibody for IHC (p), WB - ABIN4334140
Friedman, Van Laer, Huentelman, Sheth, Van Eyken, Corneveaux, Tembe, Halperin, Thorburn, Thys, Bonneux, Fransen, Huyghe, Pyykkö, Cremers, Kremer, Dhooge, Stephens, Orzan, Pfister, Bille, Parving et al.: GRM7 variants confer susceptibility to age-related hearing impairment. ... in Human molecular genetics 2009
Show all 2 Pubmed References
Human Polyclonal GRM7 Primary Antibody for ELISA, WB - ABIN447400
Vadasz, Saito, Gyetvai, Oros, Szakall, Kovacs, Prasad, Toth: Glutamate receptor metabotropic 7 is cis-regulated in the mouse brain and modulates alcohol drinking. in Genomics 2007
study to evaluate evidence for association between GRM7 and alcohol behaviors using an SNP approach, as well as a gene-based approach in two independent samples; Rs3749380 was suggestively associated with alcohol consumption in one sample with the minor T allele conferring risk; there was no evidence for association in the other sample
Autism spectrum disorder (ASD (show ARSD Antibodies)) as a synaptopathy is revealed to be pertained to aberrant glutamatergic neurotransmission. Glutamate (show GRIN1 Antibodies) receptor, metabotropic 7 (GRM7) is a receptor coding gene of this pathway.
GRM7 rs2133450 may have translational relevance as a predictor of response to risperidone in schizophrenia.
Multiple genetic models identified 1 significant locus, GRM7, for 2 hypertension-derived traits.
Study represents a genetic association test towards single variant and multi-markers interaction of GRM7 and GRM8 genes in both schizophrenia and major depressive disorders in Han Chinese population
Glutamate (show GRIN1 Antibodies) system genes have been associated with disease risk in recent analyses from the Psychiatric Genomics Consortium.
results indicate that the GRM7 SNPs rs13353402 and rs1531939 might be associated with schizophrenia in Chinese Han population.
results reported here do not support a role for GRM7 in ADHD
Copy number variants at GRM7 may have a role in the etiology of bipolar disorder.
For neither PCLO (show PCLO Antibodies) nor GRM7 we found a more associated variant. For SLC6A4 (show SLC6A4 Antibodies), we found a new SNP that showed a lower P-value than in the GAIN-MDD GWAS
mGlu7 may be a potential therapeutic target for multiple aspects of the Rett phenotype.
The mGlu7 receptor was found to be involved in a wide range of behavioral and physiological alterations in response to chronic psychosocial stress exposure.
This study provides evidence for mGlu7 receptor-mediated tonic modulation of a physiological function in vivo preventing synchronous and potentially pathological oscillations.
Analysis of mGluR7 (show GRM2 Antibodies) KO mice, c-Fos expression, and cerebral MMPIP microinjection indicate that inhibition of mGluR7 (show GRM2 Antibodies) impairs intermale aggression owing to information processing dysfunction within the bed nucleus of the stria terminalis
muscle does not appear to require high levels of SMN (show STMN1 Antibodies) above what is produced by two copies of SMN2 (show SMN1 Antibodies)
SAM68 (show KHDRBS1 Antibodies) is a physiological regulator of SMN2 (show SMN1 Antibodies) splicing in a spinal muscular atrophy mouse model.
Hyperoxia treatment increased the inclusion of SMN2 (show SMN1 Antibodies) exon 7 in skeletal muscles and resulted in improved motor function.
Elfn1 (show ELFN1 Antibodies) recruits mGluR7 (show GRM2 Antibodies) to synaptic sites.A trans interaction of Elfn1 (show ELFN1 Antibodies) and mGluR7 (show GRM2 Antibodies) controls targeted interneuron synapse development.
GRM7 regulates the phosphorylation of CREB protein and the expression of Yes-associated protein (YAP) by directly interacting with CaM, which subsequently regulates the expression of CyclinD1 and ultimately affects early cortical development.
Modeling the selective interaction between XAP044 and mGlu7's Venus flytrap domain, whose three-dimensional structure is already known, will facilitate future drug development supported by computer-assisted drug design
L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene.
metabotropic glutamate receptor 7
, G protein-coupled receptor GRM7
, G protein-coupled receptor, family C, group 1, member G
, mGlu7a receptor
, metabotropic glutamate receptor mGluR7
, metabotropic glutamate receptor subtype 7b